Wheeler Bio
Wheeler Bio is a contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing of antibody-based therapies. Using its Modular CMC platform, Wheeler Bio aims to accelerate the advancement of its partners' therapies from discovery into human clinical trials and ongoing cGMP manufacturing.
Funding Round: Series A1
Funding Amount: $35M
Date: 20-Mar-2025
Investors: Alloy Therapeutics, Echo Investment Capital (Echo), Mitsubishi Corporation (Americas), Germin8 Ventures, Russell Westbrook Enterprises
Markets: Biotech, Biomanufacturing, Healthcare
HQ: Oklahoma City, Oklahoma, United States
Founded: 2020
Website: https://www.wheelerbio.com/
LinkedIn: https://www.linkedin.com/company/wheeler-bio/
Crunchbase: https://www.crunchbase.com/organization/wheeler-bio
Leave a Comment
Comments
No comments yet.